Nutrition & Supplementation
Not all fish oil capsules are equal. Here is what peer-reviewed clinical research tells us about the benefits — and what to look for on the label.
Fish oil supplements are among the most widely sold nutritional products in the UK. But do they actually work — and are some capsules meaningfully better than others? Here is what the clinical evidence tells us, clearly and without exaggeration.
What Is Fish Oil?
Fish oil contains two types of omega-3 fat: EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). Unlike many nutrients, your body cannot produce enough of these on its own — they must come primarily from food. The richest sources are oily fish such as mackerel, salmon, sardines, herring and trout.
The British Dietetic Association (BDA) confirms that EPA and DHA play important roles in heart health, blood vessel function, lung health, and the immune and hormone systems. DHA is also essential for brain and eye development in infants.
What Does the Research Show?
❤️ Heart health: the strongest case
The cardiovascular evidence is the most consistent. A 2025 systematic review and meta-analysis of 42 clinical trials involving 176,253 participants found that omega-3 supplementation was associated with significant reductions in cardiovascular deaths, heart attacks (including fatal heart attacks), coronary heart disease events, and the need for procedures to clear blocked arteries (Mattumpuram et al., 2025).
The landmark VITAL trial — involving 25,871 participants followed for 5.3 years — found that 1g per day of EPA + DHA reduced heart attack rates, particularly in those eating little oily fish, though it did not significantly reduce stroke risk (Manson et al., 2018). Evidence is stronger for people who have already had a cardiac event than for preventing a first one in otherwise healthy people.
Key Finding
A 2025 meta-analysis of 42 studies and over 176,000 participants found omega-3 supplementation was associated with statistically significant reductions in cardiovascular mortality, heart attacks, and coronary heart disease events (Mattumpuram et al., 2025).
易 Brain health: emerging and encouraging
A major study published in Clinical Nutrition (December 2025) analysed 217,122 UK Biobank participants aged 40–64, followed for an average of 8.3 years. Those with the highest blood omega-3 levels had a 35–40% lower risk of developing early-onset dementia (defined as a diagnosis before age 65), even after adjusting for genetic risk, lifestyle, and cardiometabolic factors. The authors describe this as the first large-scale study to demonstrate this association specifically in people under 65 (Sala-Vila et al., 2025).
柳 Joint health
Of 20 clinical trials examining omega-3 in rheumatoid arthritis, 16 showed significant improvements in disease outcomes including joint stiffness and tenderness (Gioxari et al., 2017). Fish oil is considered a safe addition to existing treatment — though it does not replace prescribed medicines. Evidence in osteoarthritis is weaker and less consistent.
李 Mental health: a mixed picture
Some trials suggest modest benefits for anxiety, and moderate-dose omega-3 supplementation has shown anti-inflammatory effects relevant to mood. However, large studies — including a sub-trial of VITAL — found no benefit for preventing depression in the general population. The BDA does not currently recommend fish oil supplements specifically for mental health, and the evidence remains genuinely mixed.
⚠️ NHS Position
Standard fish oil supplements are not routinely prescribed on the NHS for the general population, as evidence of population-wide benefit remains inconclusive. The NHS recommends getting omega-3 through food first: two portions of fish per week, one of which should be oily (around 140g). The exception is icosapent ethyl (Vazkepa®) — a prescription-only, highly purified EPA preparation licensed for people at very high cardiovascular risk who are already on statins. This is a medicine, not an over-the-counter supplement.
How to Choose a Good Supplement
| What to Check | What to Look For |
|---|---|
| EPA + DHA content | At least 450mg combined EPA + DHA per daily dose (SACN recommendation). A "1,000mg fish oil" capsule may contain only ~300mg of actual EPA + DHA — always read the Supplement Facts panel. |
| Form of omega-3 | Choose triglyceride (TG) or re-esterified triglyceride (rTG) form. Research shows rTG form achieves 124% the bioavailability of standard fish oil; ethyl ester (EE) form achieves just 73% (Dyerberg et al., 2010). If the label doesn't specify form, assume ethyl ester. |
| Third-party testing | Look for IFOS 5-star certification, GOED, or NSF International. Around half of fish oils on the market fail oxidation standards — meaning the oil is stale. The total oxidation (TOTOX) value should be below 26. |
| Fish source | Supplements from smaller fish (sardines, anchovies) carry lower contamination risk. MSC (Marine Stewardship Council) certification indicates sustainably sourced fish. |
| When to take it | Always take with a fat-containing meal. This significantly improves absorption — particularly for ethyl ester capsules. Enteric-coated capsules reduce fishy aftertaste. |
| Avoid during pregnancy | Do not take cod liver oil if pregnant or planning pregnancy — it contains high levels of vitamin A, which can harm a developing baby. Choose standard fish oil instead, and follow NHS guidance on limiting oily fish to two portions per week. |
Is It Safe?
The European Food Safety Authority (EFSA) considers up to 5g of combined EPA + DHA per day safe for adults. For general health, however, the SACN target of 450mg is sufficient — and most people do not need high-dose supplementation. Doses above 3g per day should only be taken under medical supervision, as higher amounts may affect blood clotting. If you take warfarin or any other blood-thinning medicine, speak to your GP before starting a fish oil supplement.
The Bottom Line
Two portions of oily fish per week remains the gold standard — it is the most evidence-backed, cost-effective, and nutrient-rich way to get your omega-3s. If that is not consistently possible, a well-chosen supplement is a reasonable addition. Look for at least 450mg combined EPA + DHA, in triglyceride or re-esterified triglyceride form, with independent third-party certification. Take it with food, and be realistic: supplements support a healthy lifestyle — they do not replace one.
Not Sure Where to Start?
If you are considering fish oil supplements and have an existing health condition — particularly a heart condition, rheumatoid arthritis, or if you are pregnant — always speak to your GP or a registered dietitian first. The BDA's Fish Fact Sheet (www.bda.uk.com) is a trusted, free resource for further guidance.
References
British Dietetic Association (2021) Omega-3 [Food Fact Sheet]. Available at: https://www.bda.uk.com/resource/omega-3.html (Accessed: 30 May 2026).
Dyerberg, J., Madsen, P., Møller, J.M., Aardestrup, I. and Schmidt, E.B. (2010) 'Bioavailability of marine n-3 fatty acid formulations', Prostaglandins, Leukotrienes and Essential Fatty Acids, 83(3), pp. 137–141. Available at: https://pubmed.ncbi.nlm.nih.gov/20638827/ (Accessed: 30 May 2026).
Gioxari, A., Kaliora, A.C., Marantidou, F. and Panagiotakos, D.P. (2017) 'Intake of ω-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: A systematic review and meta-analysis', Nutrition, 45, pp. 114–124. Available at: https://journals.lww.com/jclinrheum/fulltext/2017/09000/omega_3_fatty_acids_in_rheumatic_diseases__a.6.aspx (Accessed: 30 May 2026).
Manson, J.E., Cook, N.R., Lee, I-M. et al. (2018) 'Marine n-3 fatty acids and prevention of cardiovascular disease and cancer', New England Journal of Medicine, 380(1), pp. 23–32. Available at: https://www.nejm.org/doi/full/10.1056/NEJMoa1811403 (Accessed: 30 May 2026).
Mattumpuram, J. et al. (2025) 'Effect of omega-3 fatty acids on cardiovascular disease risk: a systematic review and meta-analysis with meta-regression', Clinical and Translational Discovery, 5, e70094. DOI: 10.1002/ctd2.70094. Available at: https://onlinelibrary.wiley.com/doi/10.1002/ctd2.70094 (Accessed: 30 May 2026).
NHS (2022) Omega-3 fatty acids patient information leaflet [Online]. Available at: https://www.hweclinicalguidance.nhs.uk/prescribing-guidance/omega-3-fatty-acids-patient-information-leaflet/ (Accessed: 30 May 2026).
Sala-Vila, A., Tintle, N.L., Westra, J. and Harris, W.S. (2025) 'Blood omega-3 is inversely related to risk of early-onset dementia', Clinical Nutrition, 57, 106559. DOI: 10.1016/j.clnu.2025.106559. Available at: https://doi.org/10.1016/j.clnu.2025.106559 (Accessed: 30 May 2026).
IMPORTANT MEDICAL DISCLAIMER
The content provided in this blog post is for educational and informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Always consult with a qualified healthcare professional or your GP before starting any new supplement regimen, particularly if you manage pre-existing conditions or take prescription medication.
No comments:
Post a Comment